2010 - TTS International Congress


This page contains exclusive content for the member of the following sections: TTS. Log in to view.

Complications Infections

29.18 - Infection with the BK-Polyoma Virus after Renal Transplantation

Presenter: Dominik, Steubl, Munich, Germany
Authors: Steubl D., Baumann M., Fischereder M., Krämer B., Heemann U., Lutz J.

INFECTION WITH THE BK-POLYOMA VIRUS AFTER RENAL TRANSPLANTATION

COMPLICATIONS - INFECTIONS

D. Steubl1, M. Baumann1, M. Fischereder2, B. Krämer3, U. Heemann1, J. Lutz1
1Department Of Nephrology, University hospital rechts der Isar, Munich, Munich/GERMANY, 2Medizinische Poliklinik Innenstadt, Klinkum der Ludwig-Maximilian-Universität, München, Munich/GERMANY, 3Medizinische Klinik I, Marienhospital Herne, Herne/GERMANY

Body: Background: BK-Virus (BKV)-infection is associated with a severe impairment of graft function and even graft loss. Some risk factors have benn identified.However, how to adapt the immunosuppressive therapy is not clear so far.

Methods: This retrospective study was performed at the transplant centers of the university hospitals in Munich and Regensburg. We compared 57 renal transplantrecipients with BKV-replication with 71 transplant recipients who had no BKV-replication to identify potential risk factors for the development of a BKV-infection. Furthermore, we compared outcomeand graft function in patients with BKV-replication, in whom mycophenolate (MMF) was discontinued with an additional dose reduction of the remaining immunosuppressants versus patients where MMF wasmaintained with a dose reduction of MMF together with the other immunosuppressants.

Results: Patients with BKV-infection received significantly more MMF (p<0.01), were more often on a triple-immunosuppression with tacrolimus (p<0.01,p=0.034), had a higher tacrolimus serum-concentration (p=0.002), a lower lymphocyte count (p=0.006), a longer warm ischemic time (p=0.019), were more often male (p=0.026). Patients in whom MMF wasstopped had a higher chance for a clearance of BKV infection (p=0.022). Furthermore, BKV-clearance was achieved quicker as compared to patients maintained on MMF (p=0.048). Graft function was betterand there were no graft losses in patients in whom MMF was discontinued (p=0.04).

Conclusions: MMF and Tacrolimus could play an important role in the development on BKV-infection after renal transplantation. Discontinuation of MMF with areduction of the remaining immunosuppression could be an option to interfere with the BKV-infection.

Disclosure: All authors have declared no conflicts of interest.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada